{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T13:41:31Z","timestamp":1781271691269,"version":"3.54.1"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006360","name":"Bundesministerium f\u00fcr Wirtschaft und Klimaschutz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006360","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004403","name":"Th\u00fcringer Aufbaubank","doi-asserted-by":"publisher","award":["2016 IZN 0009"],"award-info":[{"award-number":["2016 IZN 0009"]}],"id":[{"id":"10.13039\/501100004403","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["316213987"],"award-info":[{"award-number":["316213987"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC 1278"],"award-info":[{"award-number":["CRC 1278"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004404","name":"Th\u00fcringer Ministerium f\u00fcr Bildung, Wissenschaft und Kultur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004404","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021130","name":"Bundesministerium f\u00fcr Wirtschaft und Klimaschutz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.mtbio.2025.102587","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:50:28Z","timestamp":1764175828000},"page":"102587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Advancing influenza virus treatment: in vitro and ex vivo studies of PI3K inhibitor-loaded lipid nanoparticles"],"prefix":"10.1016","volume":"35","author":[{"given":"Josefine","family":"Schroeder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8475-5683","authenticated-orcid":false,"given":"Jana","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1724-2725","authenticated-orcid":false,"given":"Caroline T.","family":"Holick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5917-9527","authenticated-orcid":false,"given":"Johannes","family":"Jungwirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Klement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Hoeppener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Kosan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9163-5682","authenticated-orcid":false,"given":"Michaela","family":"Schmidtke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"L\u00f6ffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0712-5255","authenticated-orcid":false,"given":"Christine","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9527-7763","authenticated-orcid":false,"given":"Ulrich S.","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8879-6087","authenticated-orcid":false,"given":"Christina","family":"Ehrhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mtbio.2025.102587_bib1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1542\/peds.2012-1255","article-title":"The burden of influenza in young children, 2004-2009","volume":"131","author":"Poehling","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.mtbio.2025.102587_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2013.09.013","article-title":"Influenza cost and cost-effectiveness studies globally \u2013 a review","volume":"31","author":"Peasah","year":"2013","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.mtbio.2025.102587_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/irv.12317","article-title":"Burden of influenza-associated deaths in the Americas, 2002-2008","volume":"9","author":"Cheng","year":"2015","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.mtbio.2025.102587_bib4","first-page":"659","article-title":"Influenza update: a review of currently available vaccines","volume":"36","author":"Clayville","year":"2011","journal-title":"P T"},{"key":"10.1016\/j.mtbio.2025.102587_bib5","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Estimates of global seasonal influenza-associated respiratory mortality: a modelling study","volume":"391","author":"Iuliano","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.mtbio.2025.102587_bib6","doi-asserted-by":"crossref","first-page":"19123","DOI":"10.1073\/pnas.0607614103","article-title":"Influenza virus pleiomorphy characterized by cryoelectron tomography","volume":"103","author":"Harris","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mtbio.2025.102587_bib7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/mr.56.1.152-179.1992","article-title":"Evolution and ecology of influenza A viruses","volume":"56","author":"Webster","year":"1992","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.mtbio.2025.102587_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fmicb.2020.00135","article-title":"Broadly protective strategies against influenza viruses: universal vaccines and therapeutics","volume":"11","author":"Vogel","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.mtbio.2025.102587_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00018-025-05611-1","article-title":"Antiviral strategies against influenza virus: an update on approved and innovative therapeutic approaches","volume":"82","author":"Bonomini","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.mtbio.2025.102587_bib10","article-title":"Prophylaxis and treatment of influenza: options, antiviral susceptibility, and existing recommendations","volume":"9","author":"Duwe","year":"2021","journal-title":"GMS Infect Dis."},{"key":"10.1016\/j.mtbio.2025.102587_bib11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.coviro.2014.04.009","article-title":"The epidemiology and spread of drug resistant human influenza viruses","volume":"8","author":"Hurt","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.mtbio.2025.102587_bib12","article-title":"The two sides of the same coin-influenza virus and intracellular signal transduction","author":"Ludwig","year":"2019","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.mtbio.2025.102587_bib13","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nature08699","article-title":"Human host factors required for influenza virus replication","volume":"463","author":"Konig","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.mtbio.2025.102587_bib14","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","article-title":"The PI3K pathway in human disease","volume":"170","author":"Fruman","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.mtbio.2025.102587_bib15","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4161\/viru.20932","article-title":"Influenza A viruses and PI3K: are there time, place and manner restrictions?","volume":"3","author":"Ayllon","year":"2012","journal-title":"Virulence"},{"key":"10.1016\/j.mtbio.2025.102587_bib16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/B978-0-12-396456-4.00002-X","article-title":"HijAkt: the PI3K\/Akt pathway in virus replication and pathogenesis","volume":"106","author":"Dunn","year":"2012","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.mtbio.2025.102587_bib17","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.mtbio.2025.102587_bib18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/ot9.0000000000000018","article-title":"FGF2 promotes the chemotherapy resistance in colon cancer cells through activating PI3K\/Akt signaling pathway","volume":"9","author":"Jian","year":"2023","journal-title":"Oncol. Trans. Med."},{"key":"10.1016\/j.mtbio.2025.102587_bib19","article-title":"Evaluation of SARS-CoV-2 spike S1 protein response on PI3K-Mediated IL-8 release","volume":"9","author":"Borchers","year":"2021","journal-title":"Med. Sci."},{"key":"10.1016\/j.mtbio.2025.102587_bib20","doi-asserted-by":"crossref","first-page":"6022","DOI":"10.1128\/JVI.75.13.6022-6032.2001","article-title":"Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling","volume":"75","author":"Johnson","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.mtbio.2025.102587_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000141","article-title":"Phosphoinositide-3 kinase-Akt pathway controls cellular entry of Ebola virus","volume":"4","author":"Saeed","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.mtbio.2025.102587_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20092188","article-title":"PI3K\/AKT\/mTOR signaling regulates the Virus\/Host cell crosstalk in HPV-Positive cervical cancer cells","volume":"20","author":"Bossler","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2025.102587_bib23","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/j.1462-5822.2006.00713.x","article-title":"Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defence","volume":"8","author":"Ehrhardt","year":"2006","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.mtbio.2025.102587_bib24","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1462-5822.2009.01309.x","article-title":"A new player in a deadly game: influenza viruses and the PI3K\/Akt signalling pathway","volume":"11","author":"Ehrhardt","year":"2009","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.mtbio.2025.102587_bib25","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1462-5822.2010.01556.x","article-title":"Influenza A virus-induced early activation of ERK and PI3K mediates V-ATPase-dependent intracellular pH change required for fusion","volume":"13","author":"Marjuki","year":"2011","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.mtbio.2025.102587_bib26","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1111\/j.1462-5822.2011.01680.x","article-title":"Phosphatidylinositol-3-kinase (PI3K) is activated by influenza virus vRNA via the pathogen pattern receptor Rig-I to promote efficient type I interferon production","volume":"13","author":"Hrincius","year":"2011","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.mtbio.2025.102587_bib27","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1128\/JVI.02082-06","article-title":"Influenza A virus NS1 protein activates the PI3K\/Akt pathway to mediate antiapoptotic signaling responses","volume":"81","author":"Ehrhardt","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.mtbio.2025.102587_bib28","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jep.2011.01.005","article-title":"Mechanism of action of the suppression of influenza virus replication by Ko-Ken Tang through inhibition of the phosphatidylinositol 3-kinase\/Akt signaling pathway and viral RNP nuclear export","volume":"134","author":"Wu","year":"2011","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.mtbio.2025.102587_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mtbio.2025.102587_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107930","article-title":"Drug repurposing for COVID-19: approaches, challenges and promising candidates","volume":"228","author":"Ng","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.mtbio.2025.102587_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23136880","article-title":"L-Lysine-Acetylsalicylate + glycine (LASAG) reduces SARS-CoV-2 replication and shows an additive effect with Remdesivir","volume":"23","author":"Jungwirth","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2025.102587_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914584","article-title":"The local anaesthetic procaine prodrugs ProcCluster((R)) and procaine hydrochloride impair SARS-CoV-2 replication and egress in vitro","volume":"24","author":"Haring","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2025.102587_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1422651","article-title":"ProcCluster((R)) and procaine hydrochloride inhibit the replication of influenza A virus in vitro","volume":"15","author":"Haring","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.mtbio.2025.102587_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/biom11060808","article-title":"Inhibition of phosphatidylinositol 3-Kinase by pictilisib blocks influenza virus propagation in cells and in lungs of infected mice","volume":"11","author":"Deinhardt-Emmer","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.mtbio.2025.102587_bib35","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.1038\/s41467-023-41442-z","article-title":"Proteomic and genetic analyses of influenza A viruses identify pan-viral host targets","volume":"14","author":"Haas","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2025.102587_bib36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13058-018-1015-x","article-title":"A phase Ib study of pictilisib (GDC-0941) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole in advanced breast cancer","volume":"20","author":"Sch\u00f6ffski","year":"2018","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.mtbio.2025.102587_bib37","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1634\/theoncologist.2017-0090","article-title":"A phase I dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with erlotinib in patients with advanced solid tumors","volume":"22","author":"Leong","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.mtbio.2025.102587_bib38","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1158\/1078-0432.CCR-14-0947","article-title":"First-in-human phase I study of pictilisib (GDC-0941), a potent pan-class I phosphatidylinositol-3-kinase (PI3K) inhibitor, in patients with advanced solid tumors","volume":"21","author":"Sarker","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mtbio.2025.102587_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14092161","article-title":"PI3K inhibitors in advanced breast cancer: the past, the present, new challenges and future perspectives","volume":"14","author":"Fuso","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mtbio.2025.102587_bib40","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1182\/hematology.2020000119","article-title":"Managing toxicities of phosphatidylinositol-3-kinase (PI3K) inhibitors","volume":"2020","author":"Hanlon","year":"2020","journal-title":"Hematol. Am. Soc. Hematol. Educat. Prog."},{"key":"10.1016\/j.mtbio.2025.102587_bib41","first-page":"209","article-title":"From the bench to the bed side: PI3K pathway inhibitors in clinical development","volume":"347","author":"Maira","year":"2010","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.mtbio.2025.102587_bib42","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.antiviral.2013.04.008","article-title":"Development of cellular signaling pathway inhibitors as new antivirals against influenza","volume":"98","author":"Planz","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.mtbio.2025.102587_bib43","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1021\/acsmaterialsau.3c00032","article-title":"Lipid-based nanoparticles for drug\/gene delivery: an overview of the production techniques and difficulties encountered in their industrial development","volume":"3","author":"Mehta","year":"2023","journal-title":"ACS Mater. Au"},{"key":"10.1016\/j.mtbio.2025.102587_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/ph17030329","article-title":"Lipid-based nanoparticles in delivering bioactive compounds for improving therapeutic efficacy","volume":"17","author":"Patel","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.mtbio.2025.102587_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1296091","article-title":"Lipid-based nanoparticles as drug delivery carriers for cancer therapy","volume":"14","author":"Waheed","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.mtbio.2025.102587_bib46","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.mtbio.2025.102587_bib47","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticles horizontal line from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2025.102587_bib48","article-title":"Principles of lipid nanoparticle design for mRNA delivery","volume":"3","author":"Zhang","year":"2024","journal-title":"BMEMat"},{"key":"10.1016\/j.mtbio.2025.102587_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2014.05.042","article-title":"Conventional versus stealth lipid nanoparticles: formulation and in vivo fate prediction through FRET monitoring","volume":"188","author":"Laine","year":"2014","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2025.102587_bib50","first-page":"297","article-title":"Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential","volume":"1","author":"Immordino","year":"2006","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.mtbio.2025.102587_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/nano11020391","article-title":"Astaxanthin-loaded stealth lipid nanoparticles (AST-SSLN) as potential carriers for the treatment of Alzheimer's disease: formulation development and optimization","volume":"11","author":"Santonocito","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.mtbio.2025.102587_bib52","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3389\/fmicb.2016.01355","article-title":"Encapsulation into stealth liposomes enhances the antitumor action of recombinant Cratylia mollis lectin expressed in Escherichia coli","volume":"7","author":"da Cunha","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.mtbio.2025.102587_bib53","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jconrel.2022.09.031","article-title":"Polyethylene glycol (PEG): the nature, immunogenicity, and role in the hypersensitivity of PEGylated products","volume":"351","author":"Ibrahim","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2025.102587_bib54","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1039\/D3NH00198A","article-title":"Anti-PEG antibodies enriched in the protein corona of PEGylated nanocarriers impact the cell uptake","volume":"8","author":"Deuker","year":"2023","journal-title":"Nanoscale Horiz."},{"key":"10.1016\/j.mtbio.2025.102587_bib55","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.ymthe.2021.01.030","article-title":"Allergic reactions and anaphylaxis to LNP-based COVID-19 vaccines","volume":"29","author":"Moghimi","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mtbio.2025.102587_bib56","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1021\/acs.macromol.1c01115","article-title":"Modification of hydrophobic hydrogels into a strongly adhesive and tough hydrogel by electrostatic interaction","volume":"55","author":"Huang","year":"2022","journal-title":"Macromolecules"},{"key":"10.1016\/j.mtbio.2025.102587_bib57","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/marc.201200453","article-title":"Poly(2-oxazoline)s--are they more advantageous for biomedical applications than other polymers?","volume":"33","author":"Sedlacek","year":"2012","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.mtbio.2025.102587_bib58","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/mabi.201200017","article-title":"Poly(2-ethyl-2-oxazoline) as alternative for the stealth polymer poly(ethylene glycol): comparison of in vitro cytotoxicity and hemocompatibility","volume":"12","author":"Bauer","year":"2012","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.mtbio.2025.102587_bib59","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202411354","article-title":"Poly(2-ethyl-2-oxazoline) (POx) as poly(ethylene glycol) (PEG)-lipid substitute for lipid nanoparticle formulations","volume":"21","author":"Holick","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.mtbio.2025.102587_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202404972","article-title":"Facile generation of heterotelechelic Poly(2-Oxazoline)s towards accelerated exploration of Poly(2-Oxazoline)-Based nanomedicine","volume":"63","author":"Van Guyse","year":"2024","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.mtbio.2025.102587_bib61","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1021\/acs.biomac.4c00651","article-title":"Tailored monoacyl Poly(2-oxazoline)- and Poly(2-oxazine)-Lipids as PEG-lipid alternatives for stabilization and delivery of mRNA-Lipid nanoparticles","volume":"25","author":"He","year":"2024","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.mtbio.2025.102587_bib62","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.2147\/IJN.S388066","article-title":"Combined Docetaxel\/pictilisib-loaded mPEGylated nanocarriers with dual HER2 targeting antibodies for synergistic chemotherapy of breast cancer","volume":"17","author":"Cheng","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.mtbio.2025.102587_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104233","article-title":"Hemagglutinin 222D\/G polymorphism facilitates fast intra-host evolution of pandemic (H1N1) 2009 influenza A viruses","volume":"9","author":"Seidel","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.mtbio.2025.102587_bib64","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.mtbio.2025.102587_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2024.113545","article-title":"POxylated stereocomplexes from PEtOx-b-PLA diblock copolymers","volume":"221","author":"Stafast","year":"2024","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.mtbio.2025.102587_bib66","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1760184","article-title":"C-Labeled pictilisib (GDC-0941) as a molecular tracer targeting phosphatidylinositol 3-Kinase (PI3K) for breast cancer imaging","volume":"2019","author":"Han","year":"2019","journal-title":"Contrast Media Mol. Imaging"},{"key":"10.1016\/j.mtbio.2025.102587_bib67","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1146\/annurev-matsci-080222-105636","article-title":"Polymer vesicles and lipid nanoparticles","volume":"54","author":"Luo","year":"2024","journal-title":"Annu. Rev. Mater. Res."},{"key":"10.1016\/j.mtbio.2025.102587_bib68","article-title":"High amount of lecithin facilitates oral delivery of a poorly soluble pyrazoloquinolinone ligand formulated in lipid nanoparticles: physicochemical, structural and pharmacokinetic performances","volume":"633","author":"Mitrovic","year":"2023","journal-title":"Int. J. Pharm. (Amst.)"},{"key":"10.1016\/j.mtbio.2025.102587_bib69","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ejps.2005.10.004","article-title":"Structural investigations on lipid nanoparticles containing high amounts of lecithin","volume":"27","author":"Schubert","year":"2006","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.mtbio.2025.102587_bib70","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejpb.2005.03.006","article-title":"Characterisation of surface-modified solid lipid nanoparticles (SLN):: influence of lecithin and nonionic emulsifier","volume":"61","author":"Schubert","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.mtbio.2025.102587_bib71","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-42189-3","article-title":"Lipid nanoparticles with PEG-Variant surface modifications mediate genome editing in the mouse retina","volume":"14","author":"Gautam","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2025.102587_bib72","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-024-02812-x","article-title":"Role of size, surface charge, and PEGylated lipids of lipid nanoparticles (LNPs) on intramuscular delivery of mRNA","volume":"22","author":"Kong","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.mtbio.2025.102587_bib73","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16010034","article-title":"Lipid-based nanotechnology: liposome","volume":"16","author":"Jiang","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2025.102587_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15020597","article-title":"Effect of PEG anchor and serum on lipid nanoparticles: development of a nanoparticles tracking method","volume":"15","author":"Berger","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2025.102587_bib75","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jconrel.2024.11.010","article-title":"Exploring the impact of commonly used ionizable and pegylated lipids on mRNA-LNPs: a combined and preclinical perspective","volume":"377","author":"Binici","year":"2025","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2025.102587_bib76","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.mtbio.2025.102587_bib77","doi-asserted-by":"crossref","first-page":"14022","DOI":"10.1021\/acsnano.1c05922","article-title":"Polyethylene glycol immunogenicity: theoretical, clinical, and practical aspects of anti-polyethylene glycol antibodies","volume":"15","author":"Chen","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2025.102587_bib78","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-023-00766-z","article-title":"Polyethylene glycol (PEG)-associated immune responses triggered by clinically relevant lipid nanoparticles in rats","volume":"8","author":"Wang","year":"2023","journal-title":"npj Vaccines"},{"key":"10.1016\/j.mtbio.2025.102587_bib79","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jconrel.2022.09.031","article-title":"Polyethylene glycol (PEG): the nature, immunogenicity, and role in the hypersensitivity of PEGylated products","volume":"351","author":"Ibrahim","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2025.102587_bib80","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1002\/anie.200902672","article-title":"Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives","volume":"49","author":"Knop","year":"2010","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.mtbio.2025.102587_bib81","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1021\/acs.macromol.7b02665","article-title":"POx as an alternative to PEG? A hydrodynamic and light scattering study","volume":"51","author":"Grube","year":"2018","journal-title":"Macromolecules"},{"key":"10.1016\/j.mtbio.2025.102587_bib82","doi-asserted-by":"crossref","first-page":"6520","DOI":"10.1039\/C6CS00409A","article-title":"Lipid-based nanovesicles for nanomedicine","volume":"45","author":"Grimaldi","year":"2016","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.mtbio.2025.102587_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2014.12.017","article-title":"The characterization of the human cell line Calu-3 under different culture conditions and its use as an optimized in vitro model to investigate bronchial epithelial function","volume":"69","author":"Kreft","year":"2015","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.mtbio.2025.102587_bib84","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1113\/jphysiol.2007.139840","article-title":"Coordinated release of nucleotides and mucin from human airway epithelial Calu-3 cells","volume":"584","author":"Kreda","year":"2007","journal-title":"J. Physiol."},{"key":"10.1016\/j.mtbio.2025.102587_bib85","article-title":"Cultured human airway epithelial cells (calu-3): a model of human respiratory function, structure, and inflammatory responses","volume":"2010","author":"Zhu","year":"2010","journal-title":"Crit. Care Res. Pract."},{"key":"10.1016\/j.mtbio.2025.102587_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(00)00452-X","article-title":"Characterization of the Calu-3 cell line as a tool to screen pulmonary drug delivery","volume":"208","author":"Foster","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.mtbio.2025.102587_bib87","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1165\/rcmb.2010-0157OC","article-title":"Human influenza is more effective than avian influenza at antiviral suppression in airway cells","volume":"44","author":"Hsu","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.mtbio.2025.102587_bib88","article-title":"Recent advances in the lipid nanoparticle-mediated delivery of mRNA vaccines","volume":"11","author":"Swetha","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.mtbio.2025.102587_bib89","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1007\/s13346-022-01203-9","article-title":"Standardization of an in vitro assay matrix to assess cytotoxicity of organic nanocarriers: a pilot interlaboratory comparison","volume":"12","author":"Eder","year":"2022","journal-title":"Drug. Deliv. Transl. Res."},{"key":"10.1016\/j.mtbio.2025.102587_bib90","doi-asserted-by":"crossref","first-page":"7567","DOI":"10.1021\/ja902039y","article-title":"Electrostatically mediated liposome fusion and lipid exchange with a nanoparticle-supported bilayer for control of surface charge, drug containment, and delivery","volume":"131","author":"Liu","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.mtbio.2025.102587_bib91","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.cell.2020.06.034","article-title":"The global phosphorylation landscape of SARS-CoV-2 infection","volume":"182","author":"Bouhaddou","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.mtbio.2025.102587_bib92","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12026-022-09268-x","article-title":"PI3K\/Akt\/mTOR pathway: a potential target for anti-SARS-CoV-2 therapy","volume":"70","author":"Fattahi","year":"2022","journal-title":"Immunol. Res."},{"key":"10.1016\/j.mtbio.2025.102587_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.587997","article-title":"Solid lipid nanoparticles for drug delivery: pharmacological and biopharmaceutical aspects","volume":"7","author":"Scioli Montoto","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.mtbio.2025.102587_bib94","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1359-6101(00)00026-5","article-title":"Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression","volume":"12","author":"Julkunen","year":"2001","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.mtbio.2025.102587_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/v13071362","article-title":"The mechanism behind influenza virus cytokine storm","volume":"13","author":"Gu","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.mtbio.2025.102587_bib96","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.bbrc.2014.06.077","article-title":"Inhibition of Akt kinase activity suppresses entry and replication of influenza virus","volume":"450","author":"Hirata","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mtbio.2025.102587_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103479","article-title":"The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory","volume":"24","author":"Ndeupen","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.mtbio.2025.102587_bib98","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16121521","article-title":"Effect of lipid nanoparticle physico-chemical properties and composition on their interaction with the immune system","volume":"16","author":"Catenacci","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2025.102587_bib99","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.nano.2013.12.003","article-title":"Cationic lipid nanocarriers activate toll-like receptor 2 and NLRP3 inflammasome pathways","volume":"10","author":"Lonez","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.mtbio.2025.102587_bib100","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.antiviral.2015.05.008","article-title":"Mouse lung slices: an ex vivo model for the evaluation of antiviral and anti-inflammatory agents against influenza viruses","volume":"120","author":"Liu","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.mtbio.2025.102587_bib101","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8040577","article-title":"Staphylococcus aureus lung infection results in down-regulation of surfactant Protein-A mainly caused by pro-inflammatory macrophages","volume":"8","author":"Schicke","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.mtbio.2025.102587_bib102","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.1128\/JVI.06722-11","article-title":"Strain-specific contribution of NS1-activated phosphoinositide 3-kinase signaling to influenza A virus replication and virulence","volume":"86","author":"Ayllon","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.mtbio.2025.102587_bib103","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.pupt.2011.05.001","article-title":"Exploring lung physiology in health and disease with lung slices","volume":"24","author":"Sanderson","year":"2011","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.mtbio.2025.102587_bib104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028429","article-title":"Infection of differentiated porcine airway epithelial cells by influenza virus: differential susceptibility to infection by porcine and avian viruses","volume":"6","author":"Punyadarsaniya","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.mtbio.2025.102587_bib105","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1746-6148-6-4","article-title":"Comparative distribution of human and avian type sialic acid influenza receptors in the pig","volume":"6","author":"Nelli","year":"2010","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.mtbio.2025.102587_bib106","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1186\/1743-422X-8-434","article-title":"Distribution of sialic acid receptors and influenza A virus of avian and swine origin in experimentally infected pigs","volume":"8","author":"Trebbien","year":"2011","journal-title":"Virol. J."},{"key":"10.1016\/j.mtbio.2025.102587_bib107","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00379-16","article-title":"Distribution of O-Acetylated sialic acids among target host tissues for influenza virus","volume":"2","author":"Wasik","year":"2017","journal-title":"mSphere"},{"key":"10.1016\/j.mtbio.2025.102587_bib108","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41551-021-00786-x","article-title":"Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs","volume":"5","author":"Lokugamage","year":"2021","journal-title":"Nat. Biomed. Eng."}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006425011585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006425011585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T15:35:19Z","timestamp":1773848119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006425011585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":108,"alternative-id":["S2590006425011585"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2025.102587","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancing influenza virus treatment: in vitro and ex vivo studies of PI3K inhibitor-loaded lipid nanoparticles","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2025.102587","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102587"}}